Alps Advisors Inc Corbus Pharmaceuticals Holdings, Inc. Transaction History

Alps Advisors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 07, 2020	SELL	$4.29 - $5.64 $553,092 - $727,142	-128,926 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$4.87 - $7.08 $29,176 - $42,416	-5,991 Reduced 4.44%	128,926 $628,000
Q2 2019 Aug 07, 2019	SELL	$6.6 - $7.8 $108,075 - $127,725	-16,375 Reduced 10.82%	134,917 $935,000
Q1 2019 May 01, 2019	BUY	$5.76 - $8.95 $109,555 - $170,229	19,020 Added 14.38%	151,292 $1.05 Million
Q4 2018 Feb 04, 2019	BUY	$5.26 - $7.97 $163,270 - $247,388	31,040 Added 30.66%	132,272 $772,000
Q3 2018 Oct 25, 2018	BUY	$4.65 - $7.95 $85,118 - $145,524	18,305 Added 22.07%	101,232 $764,000
Q2 2018 Aug 02, 2018	BUY	$5.05 - $6.8 $418,781 - $563,903	82,927 New	82,927 $419,000
Q4 2017 Feb 05, 2018	SELL	$6.6 - $7.78 $326,416 - $384,775	-49,457 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$5.75 - $7.75 $284,377 - $383,291	49,457	49,457 $354,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $739M
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.